Results 131 to 140 of about 2,796,329 (209)

Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis. [PDF]

Front Pharmacol, 2018
Manova M, Savova A, Vasileva M, Terezova S, Kamusheva M, Grekova D, Petkova V, Petrova G.   +7 more
europepmc   +1 more source

Conference report WHO informal consultation on the draft WHO Guideline on the phasing out of animal tests for the quality control of biological products.

Biologicals
Feavers I, Lei D, Milne C, Knezevic I, Zhou T, Kim E.   +5 more
europepmc   +1 more source

Removal of the innocuity test from The International Pharmacopoeia and WHO recommendations for vaccines and biological products.

Biologicals, 2020
Lei D, Schmidt H, Knezevic I, Zhou T, Kang HN, Kopp S.   +5 more
europepmc   +1 more source

Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: "Drug Products, Including Biological Products, that Contain Nanomaterials". [PDF]

AAPS J, 2019
de Vlieger JSB, Crommelin DJA, Tyner K, Drummond DC, Jiang W, McNeil SE, Neervannan S, Crist RM, Shah VP.   +8 more
europepmc   +1 more source

Comment on "Analysis of Pharmacokinetic and Pharmacodynamic Parameters in EU-Versus US-Licensed Reference Biological Products: Are In Vivo Bridging Studies Justified for Biosimilar Development?" [PDF]

BioDrugs, 2019
Webster CJ, Woollett GR.
europepmc   +1 more source

Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary. [PDF]

Clin Pharmacol Ther, 2017
Wang J, Johnson T, Sahin L, Tassinari MS, Anderson PO, Baker TE, Bucci-Rechtweg C, Burckart GJ, Chambers CD, Hale TW, Johnson-Lyles D, Nelson RM, Nguyen C, Pica-Branco D, Ren Z, Sachs H, Sauberan J, Zajicek A, Ito S, Yao LP.   +19 more
europepmc   +1 more source

Evaluating and Reporting the Immunogenicity Impacts for Biological Products--a Clinical Pharmacology Perspective. [PDF]

AAPS J, 2016
Wang YM, Wang J, Hon YY, Zhou L, Fang L, Ahn HY.   +5 more
europepmc   +1 more source

Pharmacist Substitution of Biological Products: Issues and Considerations. [PDF]

J Manag Care Spec Pharm, 2015
Li E, Ramanan S, Green L.
europepmc   +1 more source

Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market. [PDF]

Einstein (Sao Paulo), 2018
Scheinberg MA, Felix PAO, Kos IA, Andrade MA, Azevedo VF.   +4 more
europepmc   +1 more source

Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products. [PDF]

Patient Prefer Adherence, 2017
González CM, Carmona L, de Toro J, Batlle-Gualda E, Torralba AI, Arteaga MJ, Cea-Calvo L.   +6 more
europepmc   +1 more source